About RapidAI
With a pivotal role in enhancing clinical decision-making, this company offers a robust AI-driven platform that assists in detecting and managing severe vascular and neurovascular conditions. Leveraging intelligence from over 10 million scans, it empowers healthcare professionals in more than 2,000 hospitals to make quicker, more informed decisions. Working here not only places you at the forefront of medical technology partnerships but also within a culture dedicated to impactful innovation and elevated patient care.
Menlo Park, CaliforniaHeadquarters
2012Year Founded
$97.7MTotal Funding
SERIES_CCompany Stage
AI & Machine Learning, HealthcareIndustries
201-500Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Stock Options
Phone/Internet Stipend
Hybrid Work Options
Risks
Emerging AI healthcare startups could threaten RapidAI's market share.
RapidAI's solutions may become outdated without continuous innovation.
Data privacy concerns could arise as RapidAI expands globally.
Differentiation
RapidAI's platform uses AI to enhance stroke and aneurysm diagnostic imaging.
The company offers a centralized platform for remote access to critical patient information.
RapidAI's solutions facilitate collaborative decision-making among healthcare providers.
Upsides
RapidAI's partnership with Alaska Stroke Coalition improves stroke care in rural areas.
The company won the 2024 MedTech Breakthrough Award for 'Best Care Coordination Platform'.
FDA clearance for AngioFlow™ enhances RapidAI's stroke imaging capabilities in the U.S.
Funding
Total raised$97.71 M
Latest valuation$375.00 M
StageSERIES_C
SERIES C
6/30/2023$75
$375.00 MSERIES B
8/31/2020$25
$125.00 MCONVERTIBLE
6/30/2015N/A